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Background: There have been few studies of how personal and instrumental activities of daily living (P-ADL and I-ADL)
develop over time in older people receiving domiciliary care. This study aimed at assessing variables associated with the
development of P-ADL and I-ADL functioning over a 36-month follow-up period, with a particular focus on cognitive
functioning.
Method: In all, 1001 older people (≥70 years) receiving domiciliary care were included in a longitudinal study with three
assessments of P-ADL and I-ADL functioning during 36 months. P-ADL and I-ADL were assessed using the Lawton and
Brody’s Physical Self-Maintenance Scale and Instrumental Activities of Daily Living Scale, respectively. Mini Mental State
Examination (MMSE), diagnosis of dementia and MCI, neuropsychiatric symptoms and use of psychotropic medication
were also evaluated during the three assessments. Baseline demographic and general medical health information and
information of being a nursing home resident at follow-up were recorded. Linear mixed models were estimated.
Results: There was a significant decline in P-ADL and I-ADL functioning throughout the follow-up. A lower MMSE
sum-score, diagnosed MCI and dementia, a higher level of neuropsychiatric symptoms and the use of antipsychotics
and antidepressants recorded at each assessment were associated with a decline in both P-ADL and I-ADL functioning.
Furthermore, a decline in P-ADL and I-ADL functioning at follow-ups was associated with being male, a higher baseline
age and in poorer medical health as well as residing in a nursing home at follow-up.
Conclusion: P-ADL and I-ADL functioning in older people worsened over time. The worsening was associated with lower
MMSE sum-score, diagnosed MCI and dementia, poorer medical health, neuropsychiatric symptoms, use of psychotropic
medication and being transferred to nursing home care. Clinicians should pay close attention to the assessment and
treatment of these factors to help older people maintain their level of functioning for as long as possible.
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In older people, cognitive state and activities of daily liv-
ing (ADL) functioning are important for mortality,
institutionalization, and quality of life [1-3]. ADL de-
scribes practical everyday tasks that are necessary for
sustaining basic and more complex self-care [2,4,5].
The association between cognitive decline and decline in
ADL functioning in older people is well-known from* Correspondence: anne-sofie.helvik@ntnu.no
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unless otherwise stated.numerous of studies covering a wide range of countries
[6-11] that used both cross-sectional [10-13] and longitu-
dinal design [6-9,14-19]. The cross-sectional studies gener-
ally found that participants with cognitive impairment were
more likely to have ADL impairment, while the longitudinal
studies generally found that poorer cognitive functioning at
baseline was associated with reduced ADL functioning dur-
ing follow-up. However, with one exception [18], these lon-
gitudinal studies of older people living in a community
included only two assessments. Moreover, the sample pop-
ulations in the longitudinal community studies differed
widely: one included only women [17], some were inde-
pendent of health status [7,14], one only included healthy
people [16], two only included those without limitations inThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Helvik et al. BMC Geriatrics  (2015) 15:47 Page 2 of 13ADL functioning [9,15], and three only included those
with Alzheimer’s disease at the baseline [8,18,20]. How-
ever, to our knowledge, there have been no longitudinal
studies of older community-dwelling people who are
dependent on formal care, such as in-home nursing care
or domiciliary care.
Cognitive functioning is one of several factors important
in the decline in ADL functioning [6]. Other major risk
factors are physical limitations, such as general medical
health, weight loss, falls, chronic conditions, musculoskel-
etal impairment, higher number of prescribed drugs, and
hearing loss and/or vision deficits [6,21]. Moreover, the
decline in ADL functioning interacts with psychological
factors and/or environmental constraints [6,22], and is as-
sociated with advanced age [6]. Furthermore, some studies
have reported gender differences in how ADL functioning
declines [3,6]. Even though it has been widely studied, the
multifactorial and complex etiology for the decline in
ADL functioning [6] is not yet fully understood. To better
understand the dynamics of the mechanisms for the de-
cline in ADL functioning, a prospective study would bene-
fit from including more than two assessments of
community-dwelling individuals. A distinction between
personal activities of daily life (P-ADL) and instrumental
activities of daily life (I-ADL) make it easier to understand
the mechanisms of ADL decline. P-ADL includes personal
hygiene, bathing, dressing, eating, and moving inside the
house. I-ADL, on the other hand, includes making meals,
cleaning, shopping, household activities, managing fi-
nances, administering medication, and using transporta-
tion. Furthermore, to improve the understanding of the
relation between cognition and ADL decline, adjustments
for conditions such as dementia, the neuropsychiatric
symptom load, and use of psychotropic medication would
be helpful. Community-dwelling older people receiving
domiciliary care are a vulnerable group that is likely to
need future nursing home placement. Following such a
vulnerable group of older people may contribute to a new
understanding of the mechanisms of the decline in ADL
functioning over time.
We conducted a study to examine the association be-
tween cognitive functioning, both at the baseline and at
two follow-ups over a 36-month period, and to examine
the development in P-ADL and I-ADL functioning
assessed by the Physical Self-Maintenance Scale (P-ADL
sum-score) and the Instrumental Activities of Daily Living
Scale (I-ADL sum-score) [4], respectively. Our goal was to
see if adjusting for a number of other variables known to
have an influence on the P-ADL and I-ADL functioning
in older people would modify these associations. We
hypothesized that the P-ADL and I-ADL functioning in
older community-dwelling people receiving domiciliary
care at the baseline will decline over time, and that
this decline is associated with a worsening of cognitivefunctioning, prevalence of dementia, higher neuropsychi-
atric symptom load, use of psychotropic medication, and
type of formal care received at each follow-up assessment.
Methods
Design
This was a 36-month prospective study with three as-
sessments. The baseline assessment took place between
August 2008 and December 2010. The two follow-up as-
sessments took place after 18 and 36 months.
Participants
A representative sample of older people (≥70 years) re-
ceiving domiciliary care was recruited from 19 municipal-
ities in five counties in the eastern part of Norway. Both
rural and urban municipalities of various sizes were in-
vited to participate in the study. A random selection of
older recipients of domiciliary care with a next of kin who
saw them at least once a week was made, regardless of the
amount and kind of service received. Of 1,796 eligible
people, 795 declined to participate [23]. Those who de-
clined were more often women than men (73.0% vs.
68.1%, p = 0.004) and were older (mean age 85.0 years
with standard deviation (SD) 6.2 years vs. mean age 83.4
(SD = 5.7) years, p < 0.001) than those who were included
in the study [23]. A total of 1,001 older people receiving
domiciliary care were included.
Measures
The levels of personal and instrumental functioning (the
dependent variables) were reported by the next of kin at
all assessments and classified using Lawton and Brody’s
Physical Self-Maintenance Scale (P-ADL) and Instrumen-
tal Activities of Daily Living Scale (I-ADL) [4]. The P-ADL
sum-score is based on six items (range 6–30) with higher
scores indicating a lower level of functioning, while the I-
ADL sum-score is based on eight items (range 0–8) with a
higher score indicating better I-ADL functioning [4,24].
Lawton & Brody’s Physical Self-Maintenance Scale and
the Instrumental Activities of Daily Living Scale are
among the shorter recommended P-ADL and I-ADL
scales [25], which have been frequently used in Norwegian
and Scandinavian studies [26,27] and are suitable for ADL
assessments in community-dwelling older people, as well
as in nursing home residents [28,29].
Cognitive functioning was evaluated at each assessment
by the Mini-Mental State Examination (MMSE) [30], In-
formant Questionnaire on Cognitive Decline in the Elderly
(IQ-CODE) [31], and the Clock Drawing Test (CDT) [32].
The MMSE is a 30-point interviewer-administered screen-
ing test for cognitive impairment, where a higher score in-
dicates better cognitive functioning [30]. The IQ-CODE is
an interview with the closest proxy, who assesses observed
changes in cognitive functioning over the past ten years.
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indicate improvement and values > 3 indicate deterioration
[31]. The CDT is rated to a score of 5 for a “perfect” clock;
errors from minor to severe are given a score from 4 to 1.
Inability to make any reasonable representation of a clock
is given a zero score [32]. These measures have been trans-
lated and adapted to Norwegian conditions [33,34].
The severity of the dementia was evaluated at each as-
sessment by the Clinical Dementia Rating Scale (CDR;
[35]). The CDR assesses the severity of dementia in six do-
mains (memory, orientation, judgment and problem solv-
ing, community affairs, home and hobbies, and personal
care). A total score of 0 (no dementia), 0.5 (possible), 1
(mild), 2 (moderate), and 3 (severe dementia) is calculated
by means of an algorithm that weight priority to memory
[35,36]. CDR has been translated, validated [37], and used
in several settings in Norway [38-41].
Two physicians (SB & GS) with extensive experience in
research and clinical old age psychiatry independently diag-
nosed dementia according to the ICD-10 criteria and mild
cognitive impairment (MCI) according to the Winblad cri-
teria [42] using all the available information at each assess-
ment. In cases of disagreement, a third clinical expert was
consulted and a consensus was reached. Neuropsychiatric
symptoms were evaluated at all assessments using the
Neuropsychiatric Inventory (10-item NPI) [43] in a
translated and validated Norwegian version [44]. The
10-item version covers the following symptoms: delusion,
hallucination, euphoria, agitation/aggression, disinhibition,
irritability/lability, depression/dysphoria, anxiety, apathy/
indifference, and aberrant motor behavior. The next of kin
rated each symptom based on its occurrence the previous
four weeks. We identified three sub-syndromes of the NPI
based on a principal component analysis with direct obli-
min rotation. The components were extracted based on
the Kaiser criterion (factors with eigenvalues under 1 are
dropped) and inspection of the screen plot. We termed
the sub-syndromes “Agitation,” “Psychosis,” and “Affective
symptoms.” “Agitation” encompassed characteristics of agi-
tation/aggression, euphoria, disinhibition, aberrant motor
behavior, and irritability; “psychosis” was composed of the
characteristic of delusions and hallucinations. “Affective
symptoms” covered the characteristics of depression, anx-
iety, and apathy. The characteristic of agitation/aggression
loaded on the “Psychosis” sub-syndrome as well, but in line
with previous research and clinical experience, we chose to
include it in the “Agitation” sub-syndrome.
Psychotropic medications were grouped according
to the ATC code, as antipsychotics (N05A except lith-
ium), antidepressants (N06A), anxiolytics (N05B), hyp-
notics/sedatives (N05C), and anti-dementia medication
(N06D) (yes versus no). The information was collected
from the medical record of each individual at the initial
assessment.The General Medical Health Rating Scale was used at
the baseline to evaluate comorbidity. This is a four-point
global scale for scoring the degree of somatic illness
from very good (1) to very poor (4). The scale considers
each patient’s number of general medical conditions, the
severity of these conditions, and the use of medication
due to the conditions [45].
Demographic information including age, gender, mari-
tal status at inclusion, and municipality of residence, was
collected as a part of the general baseline examination.
Formal level of care over time was recorded as living
at home with domiciliary care, or living in a nursing
home.
Procedure
A research nurse coordinated the project and cooperated
with the health workers, who were assessors in each of
the municipalities. The assessors, mostly nurses, social
educators, and occupational therapists, interviewed par-
ticipants and their next of kin in the 19 municipalities.
Before the baseline data collection, all assessors went
through a two-day course with training in how to use
the assessment scales. Interviews with each participant
and their next of kin were performed simultaneously in
their own homes by two separate assessors. A one-day
training program was conducted prior to each follow-up
assessment.
Both written and oral study information was given to the
participants and their next of kin. Written informed consent
was obtained from both the participant and their next of kin
before the interviews were conducted. In those lacking the
capacity to give consent, the closest family proxy gave in-
formed consent on behalf of their next of kin. The project
was approved by the Regional Committee for Medical and
Health Research Ethics for Eastern Norway (S-08111b), the
Norwegian Social Science Data Services (NSD) (07–2008SI),
and the Directorate for Health and Social Affairs (08/2984).
Data analysis
Continuous socio-demographic and clinical characteristics
were presented as means and standard deviations (SD),
while frequencies and proportions were used for categorical
characteristics. An intra-class correlation coefficient (ICC)
was calculated for both outcomes, P-ADL and I-ADL, to
quantify a proportion of intra-municipality variation. There
was a significant cluster effect on the municipality level
found in both variables, confirming a hierarchical structure
in the data. Moreover, the data were collected at three times,
comprising repeated measurements for each patient. There-
fore, a linear mixed model with random intercepts for pa-
tients and nursing homes was estimated (SAS MIXED
procedure). Fixed effects for both linear and second-order
time components were included. The second-order time
component was only left in the model if it was significant.
Table 1 Characteristics of study sample at baseline
(N = 1001)
Total
Demographic
Women N (%) 683 (68.2)
Age (year) Mean (SD) 83.4 (5.7)
Single as marital status N (%) 703 (70.2)
General somatic health1
Good N (%) 155 (15.6)
Fair N (%) 392 (39.2)
Poor N (%) 346 (34.6)
Very poor N (%) 106 (10.6)
Cognitive functioning
MMSE Mean (SD) 24.5 (4.8)
Diagnoses
MCI N (%) 277 (27.7)
Dementia N (%) 415 (41.5)
Neuropsychiatric sub-syndrome score
Agitation Mean (SD) 1.7 (4.6)
Psychosis Mean (SD) 0.5 (2.0)
Affective Mean (SD) 2.9 (5.3)
Use of psychotropic medication
Antipsychotics N (%) 34 (3.4)
Antidepressants N (%) 154 (15.4)
Anxiolytics N (%) 86 (8.6)
Sedatives N (%) 218 (21.8)
Antidementia N (%) 56 (5.6)
MMSE =Mini-Mental State Examination, MCI =Mild cognitive impairment.
1Does not sum up to 1001 due to missing information.
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pendent variable, the degree of cognitive functioning
(MMSE sum-score). An interaction term between the
degree of cognitive functioning (MMSE) and time was
included into the model. For each outcome (P-ADL and
I-ADL sum-score), two different models with respect to
adjustments were estimated. In both models, adjustment
variables included demographic characteristics (age, gender,
and marital status), dementia, general somatic health, neuro-
psychiatric symptoms, and use of psychotropic medications.
The first model contained adjustment variables that were
assessed at the baseline. The second model included demo-
graphic characteristics and general somatic health, also
assessed at the baseline, while dementia, neuropsychiatric
symptoms, and use of psychotropic medications were en-
tered as longitudinal variables. Changes in level of care from
domiciliary care to nursing home care were also included in
the second model. The results of the regression analysis
were tabulated as coefficients with the corresponding 95%
confidence intervals (CI) and p-values. The P-ADL and I-
ADL sum-scores at each assessment, which were estimated
as the average value of the MMSE sum-score from the base-
line assessment, were illustrated graphically.
Analyses were performed in SAS v9.3 and SPSS v22.
P-values below 0.05 were considered statistically signifi-
cant. All tests were two-sided.
Results
Sample characteristics
At the baseline, the mean (SD) age was 83.4 (5.7) years
(see Table 1). In all, 683 (68.2%) of the participants were
women and 703 (70.2%) were single or were a widow/
widower. The mean (SD) baseline MMSE sum-score was
24.5 (4.8), and at the first and second follow-up, the
mean (SD) sum-score of MMSE was 23.1 (6.2) and 22.4
(7.4), respectively. Of the 1,001 participants at the base-
line (T1), 599 (59.8%) and 456 (45.5%) participants were
available for the second and third assessments (i.e., T2
and T3), respectively (see Figure 1). At follow-up, 86
participants (14.4%) and 114 participants (25.2%) had
been admitted to a nursing home by the second and
third assessments, respectively.
Change of P-ADL functioning over the follow-up period
The mean P-ADL sum-score increased over time (see
Table 2), indicating a worsening in P-ADL functioning,
confirmed by a linear mixed model demonstrating a sig-
nificant trend in time.
The association between cognitive functioning and P-ADL
functioning
The association between cognitive functioning, assessed
with the MMSE sum-score, and P-ADL functioning over
time was studied in two multivariate models. In the firstadjusted model (see Table 3), there was still a significant
linear time trend in P-ADL functioning. Furthermore,
poorer cognitive functioning at the baseline was associ-
ated with a stronger decline in P-ADL functioning over
time.
Table 4 presents the results from the second model,
which explores the association between the degree of
cognitive functioning and the P-ADL functioning
assessed simultaneously. As presented in the first ad-
justed model (Table 3), there was a decline in P-ADL
functioning throughout the follow-up period. Further-
more, a greater decline in P-ADL functioning over time
was found in those with a lower MMSE. In addition, be-
ing male, older, and in poorer general somatic health at
the baseline were all associated with worse P-ADL func-
tioning throughout the observation period. Among the
independent variables evaluated at all three assessments,
dementia (vs. no cognitive impairment), a higher agita-
tion sub-syndrome score and affective sub-syndrome
score, as well as use of antipsychotic medication and not
Persons with domiciliary care included at 
T1 (n=1001)
Not analyzed due to important missing information 
(n=5)
Death (n=146) 
Lost of follow-up (n=39)
Death (n=178) 
Lost of follow-up (n=224)
Persons at T2 (n=599)
Time between T1 and T23: 595.8 days (SD 67.8)
Not analyzed due to important missing information 
(n=20)
Persons at T3 (n=456)
Time between T2 and T3: 517.5 days (SD 81.5) 
Not analyzed due to important missing information 
(n=121)
Participants not evaluated on 
T2 (n=42)
Figure 1 Flow chart of participants from baseline (T1) to last follow-up (T3), with a mean (SD) follow-up time at each assessment.
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lower P-ADL functioning. Being a nursing home resi-
dent at the time of the second and third assessments
was associated with significantly poorer P-ADL function-
ing than those living at home during the same
assessments.
Figure 2 illustrates the unadjusted P-ADL develop-
ment over the follow-up period, as well as the P-ADL
development adjusted in two different ways (the two P-
ADL models). There was an upward trend in the P-ADL
values over time that was independent of the adjust-
ments made, i.e., the P-ADL functioning declines. The
degree of decline in P-ADL functioning during theTable 2 P-ADL and I-ADL score at three time points
Time point Min, Max Mean (SD) ICC municipality (%)
P-ADL
T1 6, 23 9.2 (3.5)
T2 6, 25 10.3 (4.4) 5.6
T3 6, 30 11.4 (5.2)
I-ADL
T1 0, 8 5.5 (2.3)
T2 0, 8 4.8 (2.5) 8.0
T3 0, 8 4.6 (2.7)
Higher P-ADL score indicates poorer functioning.
Lower I-ADL score indicates poorer functioning.
T1 = Baseline, T2 = The second assessment, T3 = The third assessment.follow-up period was moderated in the multivariate
models.
Change of I-ADL functioning over the follow-up period
The mean I-ADL sum-score at the three assessments
(see Table 2) indicated worsening in I-ADL functioning,
which was confirmed by the second-order growth
model. The second-order time trend showed that the I-
ADL functioning declined (lower score) over time at the
beginning of the follow-up period and flattened after the
second assessment.
The association between cognitive functioning and I-ADL
functioning
The association between cognitive functioning, assessed
with the MMSE sum-score, and I-ADL functioning over
time was studied in two adjusted models. The associ-
ation between time and cognitive functioning at the
baseline and I-ADL functioning over time was assessed
in the first adjusted model of I-ADL functioning
(Table 5). There was a significant second-order time
trend in I-ADL functioning. In addition, poorer cognitive
functioning at the baseline was associated with poorer I-
ADL functioning over time. The association between de-
gree of cognitive functioning at baseline and I-ADL
functioning became weaker over time, implying that I-
ADL functioning declined over time, but not at a con-
stant speed; the decline was faster in the beginning and
slowed down later.
Table 3 Model 1: Effects of cognitive impairment (MMSE) measured at baseline on P-ADL level over time estimated by
linear mixed model with random effects for intercepts and time1
Unadjusted regression coefficients Adjusted regression coefficients
Coeff. (95% CI) p-value2 Coeff. (95% CI) p-value2
Effect of main variables3
Time 0.27 (0.21; 0.33) <0.001 0.29 (0.23; 0.34) <0.001
MMSE at T1 −0.28 (−0.33; −0.23) <0.001 −0.12 (−0.18; −0.05) <0.001
MMSE *Time −0.008 (−0.01; −0.006) <0.001 −0.009 (−0.01; −0.006) <0.001
Effect of additional variables at T14
Socio –demographic information
Women −0.91 (−1.30; −0.52) <0.001 −0.57 (−0.92; −0.21) 0.002
Age (years) 0.11 (0.07; 0.14) <0.001 0.06 (0.04; 0.10) <0.001
Single −0.83 (−1.23; −0.43) <0.001 −0.31 (−0.68; 0.06) 0.101
General somatic health
Very poor 4.32 (3.60; 5.05) <0.001 3.32 (2.66; 3.97) <0.001
Poor 2.88 (2.35; 3.41) <0.001 2.04 (1.56; 2.52) <0.001
Fair 1.59 (1.09; 2.10) <0.001 0.97 (0.52; 1.42) <0.001
Good Reference Reference
Diagnoses
Dementia 3.98 (3.58; 4.38) <0.001 1.17 (0.53; 1.80) <0.001
MCI 0.98 (0.55; 1.40) <0.001 −0.10 (−0.53; 0.34) 0.667
No Reference Reference
Neuropsychiatric sub-syndrome score
Agitation 0.15 (0.11; 0.19) <0.001 0.04 (−0.008; 0.09) 0.106
Psychosis 0.44 (0.35; 0.53) <0.001 0.18 (0.08; 0.28) <0.001
Affective 0.15 (0.12; 0.19) <0.001 0.03 (−0.01; 0.06) 0.162
Use of psychotropic medication
Antipsychotics 1.55 (0.60; 2.50) 0.001 0.55 (−0.27; 1.37) 0.187
Antidepressants 1.12 (0.63; 1.61) <0.001 0.51 (0.06; 0.95) 0.026
Anxiolytics 1.00 (0.34; 1.65) 0.003 0.20 (−0.38; 0.77) 0.506
Sedatives 0.49 (0.03; 0.94) 0.036 0.17 (−0.23; 0.56) 0.410
Cognitive enhancers 1.91 (1.14; 2.67) <0.001 −0.61 (−1.31; 0.09) 0.088
MMSE =Mini-Mental State Examination, MCI =Mild cognitive impairment, T1 = baseline.
1All analyses were adjusted for the cluster effect due to municipality belonging.
2Bold text indicate p-value<0.05.
3The coefficients (95%CI) of the main independent variables (time, MMSE, and interaction between time and MMSE) unadjusted and adjusted for other
independent variables.
4The coefficients (95%CI) for single independent variables from the model containing time component.
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ADL functioning, which explored the time trend and the
association between cognitive functioning and I-ADL
functioning assessed simultaneously. As in the first model
(Table 5), there was a significant second-order time trend
in I-ADL functioning, i.e., a decline in I-ADL functioning
was found throughout the follow-up period, but the I-
ADL decline flattened over time. Furthermore, a more se-
vere decline in I-ADL functioning over time was found in
those with a poorer MMSE sum-score, and as in the first
model, the association between degree of cognitive func-
tioning and I-ADL functioning flattened over time.In addition, being male, older, married and in poorer
general medical health at the baseline were associated
with worse I-ADL functioning throughout the observation
period. Among the independent variables with evaluations
at all three assessments in the analysis, MCI and dementia
(versus no cognitive impairment), a higher psychosis sub-
syndrome score and affective sub-syndrome score, as well
as using antipsychotic, antidepressants, anxiolytics, and
anti-dementia medication were associated with lower I-
ADL functioning. Being a nursing home resident at the
time of the second and third assessments was associated
with significantly poorer I-ADL functioning at the same
Table 4 Model 2: Effects of cognitive impairment (MMSE) measured at three time points on P-ADL level at the same
time points estimated by linear mixed model with random effects for intercepts and time1
Unadjusted regression coefficients Adjusted regression coefficients
Coeff. (95% CI) p-value2 Coeff. (95% CI) p-value2
Effect of main variables3
Time 0.13 (0.08; 0.17) <0.001 0.08 (0.04; 0.13) <0.001
MMSE (at 3 time points) −0.30 (−0.34; −0.26) <0.001 −0.13 (−0.19; −0.08) <0.001
MMSE*Time −0.004 (−0.006; −0.002) <0.001 −0.002 (−0.004; −0.0005) 0.012
Effect of additional variables at T14
Socio –demographic information
Women 0.91 (−1.30; −0.52) <0.001 −0.49 (−0.82; −0.16) 0.003
Age (years) 0.11 (0.07; 0.14) <0.001 0.04 (0.01; 0.07) 0.003
Single −0.83 (−1.23; −0.43) <0.001 −0.17 (−0.51; 0.16) 0.311
General somatic health
Very poor 4.32 (3.60; 5.05) <0.001 2.99 (2.39; 3.59) <0.001
Poor 2.88 (2.35; 3.41) <0.001 1.77 (1.34; 2.21) <0.001
Fair 1.59 (1.09; 2.10) <0.001 0.65 (0.24; 1.06) 0.002
Good Reference Reference
Effect of additional variables at 3 time-points4
Diagnoses
Dementia 4.42 (4.04; 4.80) <0.001 1.31 (0.76; 1.86) <0.001
MCI 0.96 (0.54; 1.39) <0.001 0.18 (−0.22; 0.58) 0.369
No Reference Reference
Neuropsychiatric sub-syndrome score
Agitation 0.23 (0.19; 0.27) <0.001 0.07 (0.03; 0.10) <0.001
Psychosis 0.41 (0.33; 0.48) <0.001 0.06 (−0.01; 0.13) 0.098
Affective 0.17 (0.13; 0.20) <0.001 0.04 (0.01; 0.08) 0.007
Use of psychotropic medication
Antipsychotics 2.92 (2.07; 3.78) <0.001 0.81 (0.11; 1.50) 0.023
Antidepressants 1.61 (1.15; 2.07) <0.001 0.33 (−0.06; 0.72) 0.095
Anxiolytics 1.30 (0.71; 1.90) <0.001 0.20 (−0.28; 0.68) 0.410
Sedatives 0.81 (0.37; 1.24) <0.001 0.15 (−0.19; 0.50) 0.388
Cognitive enhancers 1.78 (1.08; 2.49) <0.001 −1.09 (−1.68; −0.49) <0.001
Effect of additional variable at T2 & T34
Nursing home care 6.45 (5.87; 7.03) <0.001 2.84 (2.19; 3.49) <0.001
MMSE= Mini-Mental State Examination, MCI= Mild cognitive impairment, T1= baseline, T2 and T3 = follow-ups.
1All analyses were adjusted for the cluster effect due to municipality belonging.
2Bold text indicate p-value<0.05.
3The coefficients (95%CI) of the main independent variables (time, MMSE, and interaction between time and MMSE) unadjusted and adjusted for other
independent variables.
4The single coefficients (95%CI) of the main independent variables from the modeling containing time components.
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assessments.
Figure 3 illustrates the unadjusted I-ADL development
over the follow-up period, as well as I-ADL development
adjusted in two different ways (the two I-ADL models). In-
dependently of the adjustments made, there is a downward
trend in the I-ADL values over time, i.e., the I-ADL func-
tioning declines, but the rate of decline flattened duringfollow-up. The degree of decline in I-ADL functioning dur-
ing follow-up was moderated in the multivariate models.
Discussion
This follow-up study of 1,001 older community-dwelling
people (≥70 years) receiving domiciliary care found that re-
duced cognitive functioning at the baseline and the course
of cognitive functioning assessed with MMSE during
Figure 2 Development of P-ADL sum-score in time, unadjusted, adjusted in Model 1 and adjusted in Model 2.
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and I-ADL functioning. Independently of the adjustments
made, there was a decline in P-ADL and I-ADL function-
ing over time. In addition, the rate of decline in I-ADL
functioning, but not P-ADL functioning, flattened during
the time of follow-up.
Numerous other authors have pointed to a relationship
between reduced cognitive functioning and worsening P-
ADL in older community-dwelling people [2,6-9,14-19],
as well as among older hospitalized patients [46], and in
nursing home residents [47]. However, to our knowledge,
few have studied the P-ADL development by time and de-
gree of cognitive functioning in older community-dwelling
people, including three or more assessments. A recent
Swedish community study of older people diagnosed with
MCI or Alzheimer’s disease conducted P-ADL assess-
ments three times during a follow-up period of eight
years, and their results supported our findings that a de-
cline in P-ADL functioning was explained by both time
and degree of cognitive impairment [18]. Our results, as
well as the results of the Swedish study, indicate the im-
portance of “tailoring” care for people with cognitive
impairment as the cognitive impairment progresses and
P-ADL decreases. As previously suggested, tailoring care
according to the patients’ increasing needs will likely
increase the quality of life for the people involved [48].
In the present study, we assessed P-ADL and I-ADL
functioning separately and at all assessments. We found a
decline in I-ADL functioning by time and cognitive func-
tioning, as we did for P-ADL functioning, but we also
found that the slope of decline in I-ADL functioning flat-
tened at the third assessment. The I-ADL assessment
covers more complex activities of daily living than the
P-ADL assessment [49]. Impairment in I-ADL functioningmay be an earlier sign of cognitive impairment [50], and the
decline may flatten at an earlier point of time than the de-
cline in P-ADL functioning. Thus, the shape of decline in P-
ADL and I-ADL functioning throughout the assessment
period may differ. However, we cannot rule out the possibil-
ity that the slope in I-ADL development may be explained
by a ceiling effect related to the assessment tool used. How-
ever, the results indicate the importance of “tailoring” care
for people with cognitive impairment as cognitive impair-
ment progresses and ADL functioning decreases.
Independent of the assessed ADL functioning outcome
(I-ADL or P-ADL functioning), we found that lower age
and better general somatic health at the baseline were
associated with better functioning throughout the assess-
ment period. These results are in accordance with findings
from other community studies assessing risk factors for
the decline of ADL functioning over time [6]. In the
present study, we have used the GMHR Scale to assess
somatic health. The scale considers each patient’s number
of general medical conditions, the severity of these condi-
tions, and the use of medication due to the conditions. It
rates the condition of somatic health from very good (1)
to very poor (4) [45]. An equally sound approach to asses-
sing somatic health difficulties could have been the use of
more detailed information about somatic comorbidity or a
comorbidity index such as the Charlson comorbidity
index [51]. It is crucial to adjust for somatic comorbidity
regardless of the assessment tool chosen when examining
the association between cognitive functioning and ADL
decline, since somatic health difficulties may have negative
consequences for cognitive functioning over time [28].
In population-based studies, men often reported higher
P-ADL and I-ADL functioning than women [3]. In the
present study, men had worse P-ADL and I-ADL
Table 5 Model 1: Effects of cognitive impairment (MMSE) measured at baseline on I-ADL level over time estimated by
linear mixed model with random effects for intercepts and time1
Unadjusted regression coefficients Adjusted regression coefficients
Coeff. (95% CI) p-value2 Coeff. (95% CI) p-value2
Effect of main variables3
Time −0.13 (−0.17; −0.09) <0.001 −0.13 (−0.17; −0.10) <0.001
Time* Time 0.0007 (0.00007; 0.001) 0.029 0.0006 (0.00001; 0.001) 0.046
MMSE at T1 0.24 (0.21; 0.26) <0.001 0.07 (0.04; 0.10) <0.001
MMSE *Time 0.003 (0.002; 0.004) <0.001 0.003 (0.002; 0.004) <0.001
Effect of additional variables at T14
Socio –demographic information
Women 0.82 (0.59; 1.04) <0.001 0.62 (0.43; 0.80) <0.001
Age (years) −0.08 (−0.10; −0.06) <0.001 −0.06 (−0.07; −0.04) <0.001
Single 0.71 (0.48; 0.95) <0.001 0.35 (0.16; 0.54) <0.001
General somatic health
Very poor −2.33 (−2.75; −1.91) <0.001 −1.51 (−1.85; −1.17) <0.001
Poor −1.72 (−2.03; −1.42) <0.001 −1.05 (−1.29; −0.80) <0.001
Fair −1.03 (−1.32; −0.74) <0.001 −0.55 (−0.78; −0.32) <0.001
Good Reference Reference
Diagnoses
Dementia −3.05 (−3.26; −2.84) <0.001 −1.40 (−1.73; −1.08) <0.001
MCI −0.84 (−1.06; −0.62) <0.001 −0.22 (−0.45; −0.003) 0.047
No Reference Reference
Neuropsychiatric sub-syndrome score
Agitation −0.10 (−0.12; −0.07) <0.001 0.02 (−0.006; 0.04) 0.155
Psychosis −0.35 (−0.40; −0.30) <0.001 −0.16 (−0.20; −0.11) <0.001
Affective −0.13 (−0.15; −0.11) <0.001 −0.04 (−0.06; −0.02) <0.001
Use of psychotropic medication
Antipsychotics −1.29 (−1.83; −0.75) <0.001 −0.49 (−0.91; −0.08) 0.019
Antidepressants −0.77 (−1.06; −0.49) <0.001 −0.34 (−0.57; −0.11) 0.003
Anxiolytics −0.76 (−1.15; −0.38) <0.001 −0.20 (−0.50; 0.10) 0.183
Sedatives −0.09 (−0.35; 0.17) 0.509 0.07 (−0.13; 0.27) 0.490
Cognitive enhancers −2.46 (−2.91; −2.02) <0.001 −0.62 (−0.99; −0.25) 0.001
MMSE= Mini-Mental State Examination, MCI= Mild cognitive impairment, T1= baseline.
1All analyses were adjusted for the cluster effect due to municipality belonging.
2Bold text indicate p-value<0.05.
3The coefficients (95%CI) of the main independent variables (time, MMSE, and interaction between time and MMSE) unadjusted and adjusted for other
independent variables.
4The coefficients (95%CI) for single independent variables from the model containing time components.
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due to the inclusion criteria used in the study, i.e., being a
recipient of domiciliary care. Nevertheless, we cannot rule
out the possibility that this trend was due to next of kin an-
swering the ADL questions. However, a prospective com-
munity study of people with dementia found that women
had better I-ADL functioning at the time of follow-up after
adjustment for cognitive functioning [20]. Furthermore, a
cross-sectional community study found that women re-
ported better I-ADL functioning than men in analysesadjusted for cognitive impairment, [10]. The authors in the
latter study explained the finding as a result of traditional
culture-related gender roles, i.e., that men were more likely
to get help with complex activities than women [10].
In the adjusted analyses, we found that participants
with dementia had worse P-ADL and I-ADL functioning
at each time point compared to participants without de-
mentia. Furthermore, we found that those with MCI had
worse I-ADL functioning, but not P-ADL functioning at
the same assessments as those without dementia. This
Table 6 Model 2: Effects of cognitive impairment (MMSE) measured at three time points on I-ADL level at the same
time points estimated by linear mixed model with random effects for intercepts and time1
Unadjusted regression coefficients Adjusted regression coefficients
Coeff. (95% CI) p-value2 Coeff. (95% CI) p-value2
Effect of main variables3
Time −0.06 (−0.09; −0.02) <0.001 −0.07 (−0.10; −0.03) <0.001
Time*Time 0.0007 (0.00009; 0.001) 0.023 0.0006 (0.0001; 0.001) 0.016
MMSE (at 3 time points) 0.25 (0.22; 0.27) <0.001 0.07 (0.04; 0.10) <0.001
MMSE*Time 0.0009 (−0.0001; 0.002) 0.081 0.001 (0.0002; 0.002) 0.021
Effect of additional variables at T14
Socio –demographic information
Women 0.82 (0.59; 1.04) <0.001 0.63 (0.46; 0.80) <0.001
Age (years) −0.08 (−0.10; −0.06) <0.001 −0.04 (−0.06; −0.03) <0.001
Single 0.71 (0.48; 0.95) <0.001 0.29 (0.11; 0.46) 0.001
General somatic health
Very poor −2.33 (−2.75; −1.91) <0.001 −1.34 (−1.65; −1.03) <0.001
Poor −1.72 (−2.03; −1.42) <0.001 −0.91 (−1.14; −0.69) <0.001
Fair −1.03 (−1.32; −0.74) <0.001 −0.43 (−0.64; −0.21) <0.001
Good Reference Reference
Effect of additional variables at 3 time-points4
Diagnoses
Dementia −3.28 (−3.47; −3.08) <0.001 −1.50 (−1.79; −1.21) <0.001
MCI −0.76 (−0.98; −0.55) <0.001 −0.26 (−0.47; −0.06) 0.012
No Reference Reference
Neuropsychiatric sub-syndrome score
Agitation −0.13 (−0.15; −0.11) <0.001 0.005 (−0.01; 0.02) 0.634
Psychosis −0.28 (−0.33; −0.24) <0.001 −0.07 (−0.11; −0.03) <0.001
Affective −0.14 (−0.15; −0.12) <0.001 −0.05 (−0.07; −0.04) <0.001
Use of psychotropic medication
Antipsychotics −1.83 (−2.34; −1.33) <0.001 −0.75 (−1.12; −0.39) <0.001
Antidepressants −0.97 (−1.24; −0.70) <0.001 −0.23 (−0.43; −0.02) 0.028
Anxiolytics −0.95 (−1.30; −0.59) <0.001 −0.29 (−0.54; −0.04) 0.026
Sedatives −0.29 (−0.55; −0.04) <0.0251 0.03 (−0.15; 0.21) 0.768
Cognitive enhancers −2.38 (−2.79; −1.98) <0.001 −0.46 (−0.78; −0.14) 0.005
Effect of additional variable at T2 & T3 2
Nursing home care −3.70 (−4.09; −3.31) <0.001 −1.16 (−1.54; −0.79) <0.001
MMSE= Mini-Mental State Examination, MCI= Mild cognitive impairment, T1= baseline, T2 and T3 = follow-ups.
1All analyses were adjusted for the cluster effect due to municipality belonging.
2Bold text indicate p-value<0.05.
3The coefficients (95%CI) of the main independent variables (time, MMSE, and interaction between time and MMSE) unadjusted and adjusted for other
independent variables.
4The single coefficients (95%CI) of the main independent variables from the modeling containing time components.
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affect complex ADL (I-ADL) functioning, but not basic
self-care (P-ADL) functioning [50], while dementia often
affects both complex and basic ADL functioning [52,53].
Interestingly, we found that worsening ADL functioning
at each assessment was associated with higher levels of
neuropsychiatric symptoms at the same assessment. Higheragitation and affective sub-syndromes scores were associated
with worsening P-ADL functioning, while higher psychosis
and affective sub-syndromes scores were associated with
worsening I-ADL functioning. To our knowledge, no previ-
ous studies have explored neuropsychiatric symptoms in rela-
tion to ADL functioning in community-dwelling older
people. However, a recent study of decline in P-ADL
Figure 3 Development of I-ADL sum-score in time, unadjusted, adjusted in Model 1 and adjusted in Model 2.
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are in line with the present study in reporting that higher
neuropsychiatric symptoms were associated with worsen-
ing P-ADL functioning [54]. Moreover, the present study
found an association between better P-ADL functioning
and the use of anti-dementia medication at the same as-
sessment, which is in line with the results of the previously
mentioned study of nursing home residents and several
randomized trials that found anti-dementia medication
important for P-ADL [25,54-56]. Lower I-ADL functioning
at each assessment was also associated with the use of anti-
dementia medication, antipsychotics, and/or antidepres-
sants, and anxiolytics were associated with lower P-ADL
and I-ADL functioning at the same assessment. In contrast
to our results, a study of psychogeriatric outpatients with
dementia reported that a low dose use of antipsychotics for
half a year did not change P-ADL or I-ADL functioning
[57]. Unfortunately, we do not have information about the
dosages and length of use of the psychotropic drugs in our
study. However, as the use of antipsychotic drugs is associ-
ated with a range of other serious adverse events, these
drugs should be used with great caution and regular evalu-
ation of effects and side effects.
Community-dwelling older people receiving domicil-
iary care represent a vulnerable group, and at assess-
ments two and three, 86 (14.4%) and 114 (25.2%)
participants had become nursing home residents, re-
spectively. Being a receiver of nursing home care at assess-
ment two and three was associated with worsening ADL
functioning at the same assessments compared to those re-
ceiving care at home. Other studies have also reported that
a decline in ADL is associated with nursing home admis-
sion [58,59]. In addition, nursing home admission is not
known to improve or stabilize ADL functioning, but ratherlowers ADL functioning during the first period after admis-
sion [60].
While the study has a number of advantages, such as
using well-known, internationally accepted P-ADL and I-
ADL assessment scales, a high number of baseline partici-
pants, use of a direct measure of cognitive functioning, and
adjustments for a high number of variables of potential
importance to the outcome, such as medical health, demo-
graphic variables, and diagnosed MCI and dementia, it
nevertheless has some limitations that need to be addressed.
First, the associations found in our study should be
interpreted with caution since our design does not allow
for inferences about causality.
Secondly, participants differed in mean age and gender
distribution from the original population, many of whom
refused participation at the baseline [23]. Even though the
participants were randomly selected, the great number of
those who declined to participate may not be random and
to some extent may have biased the representativeness of
the study population. Thus, caution should be exercised in
generalizing the study results.
Thirdly, assessments of P-ADL and I-ADL function-
ing in older people in a longitudinal study with three
follow-ups over a three years period are statistically
challenging. Repeated measurements of the same indi-
viduals imply dependency in data. Having a large num-
ber of drop-outs due to death and other reasons, leads
to a varying number of observations per individual and
generates data imbalances. Furthermore, a number
of the independent variables in the adjusted models
vary with time. However, the linear mixed model
handles any degree of imbalance in data by including
all available data [61]. It also accounts for the correla-
tions among repeated measurements in a relatively
Helvik et al. BMC Geriatrics  (2015) 15:47 Page 12 of 13parsimonious way and allows time-varying covariates to
be included in the model [61].
Fourthly, even if information about the use psychotropic
medications were available, we did not have information
about the dosages or length of the use of the psychotropic
medications. We also used a very rough assessment of
level of care, i.e. domiciliary care or nursing home care at
the second and third assessment time point. We did not
have detailed information about the degree of domiciliary
care that was provided at any assessment time point, but
we expect that individuals whose ADL functions decline a
great deal will have received more care compared with
those who performed better. Lastly, since I-ADL function
is often related to mobility [62], it would be fair to criticize
our study for not adjusting our analysis of I-ADL func-
tioning to reflect the degree of difficulty with mobility. In-
cluding adjustments for the degree of domiciliary care
provided and the degree of difficulty with mobility may
have nuanced our results further. As a consequence, we
cannot rule out that there are confounders that are not
reflected in our analyses.
Conclusion
In a large-scale longitudinal study among older people who
receive domiciliary care that included three assessments
over a 36-month period, we found that P-ADL and I-ADL
functioning declined over time. Furthermore, the worsening
of P-ADL and I-ADL functioning was associated with lower
baseline cognitive functioning and with a decline in cogni-
tive functioning during follow-up. The degree of decline in
I-ADL functioning explained by cognitive functioning de-
creased during follow-up. Clinicians should pay attention
to the associates of P-ADL and I-ADL functioning identi-
fied in this study so they can better tailor care, and thus,
help older people maintain their level of functioning as long
as possible.
Abbreviations
ATC: The Anatomic Therapeutic Chemical; CDR: Clinical Dementia Rating;
CDT: Clock Drawing Test; I-ADL: Instrumental Activities of Daily Living;
ICD-10: International Statistical Classification of Diseases and Related Health
Problems 10th Revision; IQ-CODE: Informant Questionnaire on Cognitive
Decline in the Elderly; NPI: Neuropsychiatric Inventory; MCI: Mild Cognitive
Impairment; MMSE: Mini Mental State Examination; P-ADL: Personal Activities
of Daily Living; SAS: Statistical Analysis Software; SPSS: Statistical Software
Package from IBM; T1: Baseline; T2: The second assessment; T3: The third
assessment.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ASH did some primary analysis and drafted the manuscript. GS designed and
facilitated the study and participated in the data collection. LDH was the
research nurse and responsible for data collection. SB participated in the
data collection. JSB analyzed the majority of the data for this manuscript.
ØK inspected the data that was collected. All authors participated in the
interpretation of the study results and in editing the manuscript, and have
read and approved the final manuscript.Acknowledgment
The data collection was funded by the Norwegian Directorate of Health and by
grant 187980 from the Research Council of Norway and Norwegian Centre for
Research, Education and Service Development, Innlandet Hospital Trust.
Author details
1Department of Public Health and General Practice, Faculty of Medicine,
Norwegian University of Science and Technology (NTNU), Postbox 8905,
NO7491 Trondheim, Norway. 2Norwegian National Advisory Unit on Ageing
and Health, Vestfold Hospital Trust, Tønsberg, Norway. 3St Olavs University
Hospital, Trondheim, Norway. 4Centre for Old Age Psychiatric Research,
Innlandet Hospital Trust, Ottestad, Norway. 5Institute of Clinical Medicine,
Campus Ahus, University of Oslo, Oslo, Norway. 6HØKH, Research Centre,
Akershus University Hospital, Lørenskog, Norway. 7Faculty of Health, Care and
Nursing, Gjøvik University College, Gjøvik, Norway. 8Akershus University
Hospital, Lørenskog, Norway.
Received: 17 December 2014 Accepted: 31 March 2015
References
1. Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, Hebert R,
et al. Prevalence, attributes, and outcomes of fitness and frailty in
community-dwelling older adults: report from the Canadian study of health
and aging. J Gerontol A Biol Sci Med Sci. 2004;59:1310–7.
2. Barberger-Gateau P, Fabrigoule C. Disability and cognitive impairment in
the elderly. Disabil Rehabil. 1997;19:175–93.
3. von Strauss E, Aguero-Torres H, Kareholt I, Winblad B, Fratiglioni L. Women
are more disabled in basic activities of daily living than men only in very
advanced ages: a study on disability, morbidity, and mortality from the
Kungsholmen Project. J Clin Epidemiol. 2003;56:669–77.
4. Lawton MP, Brody EM. Assessment of older people: self-maintaining and
instrumental activities of daily living. Gerontologist. 1969;9:179–86.
5. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index
of ADL. Gerontologist. 1970;10:20–30.
6. Stuck AE, Walthert JM, Nikolaus T, Bula CJ, Hohmann C, Beck JC. Risk factors
for functional status decline in community-living elderly people: a
systematic literature review. Soc Sci Med. 1999;48:445–69.
7. Dodge HH, Kadowaki T, Hayakawa T, Yamakawa M, Sekikawa A, Ueshima H.
Cognitive impairment as a strong predictor of incident disability in specific
ADL-IADL tasks among community-dwelling elders: the Azuchi Study.
Gerontologist. 2005;45:222–30.
8. Solomon A, Dobranici L, Kareholt I, Tudose C, Lazarescu M. Comorbidity and
the rate of cognitive decline in patients with Alzheimer dementia. Int J
Geriatr Psychiatry. 2011;26:1244–51.
9. Alexandre Tda S, Corona LP, Nunes DP, Santos JL, Duarte YA, Lebrao ML.
Gender differences in incidence and determinants of disability in activities
of daily living among elderly individuals: SABE study. Arch Gerontol Geriatr.
2012;55:431–7.
10. Millan-Calenti JC, Tubio J, Pita-Fernandez S, Gonzalez-Abraldes I, Lorenzo T,
Fernandez-Arruty T, et al. Prevalence of functional disability in activities of daily
living (ADL), instrumental activities of daily living (IADL) and associated factors,
as predictors of morbidity and mortality. Arch Gerontol Geriatr. 2010;50:306–10.
11. Ha E, Kim K. Factors that influence activities of daily living in the elderly
with probable dementia. J Psychiatr Ment Health Nurs. 2014;21:447–54.
12. Grigsby J, Kaye K, Baxter J, Shetterly SM, Hamman RF. Executive cognitive
abilities and functional status among community-dwelling older persons in
the San Luis Valley Health and Aging Study. J Am Geriatr Soc.
1998;46:590–6.
13. Arias-Merino ED, Mendoza-Ruvalcaba NM, Ortiz GG, Velazquez-Brizuela IE,
Meda-Lara RM, Cueva-Contreras J. Physical function and associated factors
in community-dwelling elderly people in Jalisco, Mexico. Arch Gerontol
Geriatr. 2012;54:e271–8.
14. Beland F, Zunzunegui MV. Predictors of functional status in older people
living at home. Age Ageing. 1999;28:153–9.
15. Mehta KM, Yaffe K, Covinsky KE. Cognitive impairment, depressive
symptoms, and functional decline in older people. J Am Geriatr Soc.
2002;50:1045–50.
16. Ishizaki T, Yoshida H, Suzuki T, Watanabe S, Niino N, Ihara K, et al. Effects of
cognitive function on functional decline among community-dwelling
non-disabled older Japanese. Arch Gerontol Geriatr. 2006;42:47–58.
Helvik et al. BMC Geriatrics  (2015) 15:47 Page 13 of 1317. Johnson JK, Lui LY, Yaffe K. Executive function, more than global cognition,
predicts functional decline and mortality in elderly women. J Gerontol A
Biol Sci Med Sci. 2007;62:1134–41.
18. Handels RL, Xu W, Rizzuto D, Caracciolo B, Wang R, Winblad B, et al. Natural
progression model of cognition and physical functioning among people
with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis.
2013;37:357–65.
19. Black SA, Rush RD. Cognitive and functional decline in adults aged 75 and
older. J Am Geriatr Soc. 2002;50:1978–86.
20. Benke T, Delazer M, Sanin G, Schmidt H, Seiler S, Ransmayr G, et al.
Cognition, gender, and functional abilities in Alzheimer’s disease: how are
they related? J Alzheimers Dis. 2013;35:247–52.
21. Vermeulen J, Neyens JC, van Rossum E, Spreeuwenberg MD, de Witte LP.
Predicting ADL disability in community-dwelling elderly people using
physical frailty indicators: a systematic review. BMC Geriatr. 2011;11:33.
22. Fauth EB, Schwartz S, Tschanz JT, Ostbye T, Corcoran C, Norton MC. Baseline
disability in activities of daily living predicts dementia risk even after
controlling for baseline global cognitive ability and depressive symptoms.
Int J Geriatr Psychiatry. 2013;28:597–606.
23. Wergeland JN, Selbaek G, Hogset LD, Soderhamn U, Kirkevold O. Dementia,
neuropsychiatric symptoms, and the use of psychotropic drugs among
older people who receive domiciliary care: a cross-sectional study.
Int Psychogeriatr. 2014;26:383–91.
24. Graf C. The Lawton instrumental activities of daily living (IADL) scale.
Medsurg Nurs. 2008;17:343–4.
25. Potkin SG. The ABC of Alzheimer’s disease: ADL and improving day-to-day
functioning of patients. Int Psychogeriatr. 2002;14 Suppl 1:7–26.
26. Selbaek G, Kirkevold O, Engedal K. The prevalence of psychiatric symptoms
and behavioural disturbances and the use of psychotropic drugs in
Norwegian nursing homes. Int J Geriatr Psychiatry. 2007;22:843–9.
27. Helvik A-S, Skancke RH, Selbaek G. Screening for depression in elderly
medical inpatients from rural area of Norway: prevalence and associated
factors. Int J Geriatr Psychiatry. 2010;25:150–9.
28. Helvik AS, Selbaek G, Engedal K. Cognitive decline one year after
hospitalization in older adults without dementia. Dement Geriatr Cogn
Disord. 2012;34:198–205.
29. Bergh S, Holmen J, Saltvedt I, Tambs K, Selbaek G. Dementia and
neuropsychiatric symptoms in nursing-home patients in Nord-Trondelag
County. Tidsskr Nor Laegeforen. 2012;132:1956–9.
30. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical
method for grading the cognitive state of patients for the clinician.
J Psychiatr Res. 1975;12:189–98.
31. Jorm AF. The Informant Questionnaire on cognitive decline in the elderly
(IQCODE): a review. Int Psychogeriatr. 2004;16:275–93.
32. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J
Geriatr Psychiatry. 2000;15:548–61.
33. Engedal K, Haugen P, Gilje K, Laake P. Efficacy of short mental tests in the
detection of mental impairment in old age. Compr Gerontol A. 1988;2:87–93.
34. Nesset M, Kersten H, Ulstein ID. Brief tests such as the Clock Drawing Test
Or Cognistat can be useful predictors of conversion from MCI to dementia
in the clinical assessment of outpatients. Dement Geriatr Cogn Dis Extra.
2014;4:263–70.
35. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale
for the staging of dementia. Br J Psychiatry. 1982;140:566–72.
36. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring
rules. Neurology. 1993;43:2412–4.
37. Engedal K, Haugen PK. The prevalence of dementia in a sample of elderly
Norwegians. Int J Geriatr Psychiatry. 1993;8:565–70.
38. Kirkevold O, Sandvik L, Engedal K. Use of constraints and their correlates in
Norwegian nursing homes. Int J Geriatr Psychiatry. 2004;19:980–8.
39. Lystrup LS, Lillesveen B, Nygard AM, Engedal K. [Public social health services
to demented persons living at home in Norway]. Tidsskr Nor Laegeforen.
2006;126:1917–20.
40. Thygesen E, Saevareid HI, Lindstrom TC, Nygaard HA, Engedal K. Predicting
needs for nursing home admission - does sense of coherence delay nursing
home admission in care dependent older people? A longitudinal study.
Int J Older People Nurs. 2009;4:12–21.
41. Helvik AS, Engedal K, Selbaek G. Perceived health among the medically
hospitalized elderly: a one-year follow-up study. Scand J Public Health.
2013;41:421–8.42. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al.
Mild cognitive impairment–beyond controversies, towards a consensus:
report of the international working group on mild cognitive impairment. J
Intern Med. 2004;256:240–6.
43. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology
in dementia patients. Neurology. 1997;48:S10–6.
44. Selbaek G, Kirkevold O, Sommer OH, Engedal K. The reliability and validity of
the Norwegian version of the Neuropsychiatric Inventory, nursing home
version (NPI-NH). Int Psychogeriatr. 2008;20:375–82.
45. Lyketsos CG, Galik E, Steele C, Steinberg M, Rosenblatt A, Warren A, et al.
The general medical health rating: a bedside global rating of medical
comorbidity in patients with dementia. J Am Geriatr Soc. 1999;47:487–91.
46. Hoogerduijn JG, Schuurmans MJ, Duijnstee MS, de Rooij SE, Grypdonck MF.
A systematic review of predictors and screening instruments to identify
older hospitalized patients at risk for functional decline. J Clin Nurs.
2007;16:46–57.
47. Gillen P, Spore D, Mor V, Freiberger W. Functional and residential status
transitions among nursing home residents. J Gerontol A Biol Sci Med Sci.
1996;51:M29–36.
48. Bryla M, Burzynska M, Maniecka-Bryla I. Self-rated quality of life of city-
dwelling elderly people benefitting from social help: results of a cross-
sectional study. Health Qual Life Outcomes. 2013;11:181.
49. Bennett JA. Activities of daily living. Old-fashioned or still useful? J Gerontol
Nurs. 1999;25:22–9.
50. Albert SM, Tabert MH, Dienstag A, Pelton G, Devanand D. The impact of
mild cognitive impairment on functional abilities in the elderly. Curr
Psychiatry Rep. 2002;4:64–8.
51. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis. 1987;40:373–83.
52. Giebel CM, Sutcliffe C, Challis D. Activities of daily living and quality of life
across different stages of dementia: a UK study. Aging Ment Health.
2015;19:63–71.
53. Gold DA. An examination of instrumental activities of daily living
assessment in older adults and mild cognitive impairment. J Clin Exp
Neuropsychol. 2012;34:11–34.
54. Helvik AS, Engedal K, Benth JS, Selbaek G. A 52 month follow-up of
functional decline in nursing home residents - degree of dementia
contributes. BMC Geriatr. 2014;14:45.
55. Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang R, et al.
Effects of donepezil on activities of daily living: integrated analysis of patient
data from studies in mild, moderate and severe Alzheimer’s disease. Int
Psychogeriatr. 2010;22:973–83.
56. Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in
older adults: a narrative review. Am J Geriatr Pharmacother. 2011;9:378–91.
57. Angelini A, Bendini C, Neviani F, Neri M. Behavioral and psychological
symptoms of dementia (BPSD) in elderly demented subjects: is the long
lasting use of atypical antipsychotic drugs useful and safe? Arch Gerontol
Geriatr. 2007;44 Suppl 1:35–43.
58. Gaugler JE, Duval S, Anderson KA, Kane RL. Predicting nursing home
admission in the US: a meta-analysis. BMC Geriatr. 2007;7:13.
59. Van Rensbergen G, Pacolet J. Instrumental Activities of Daily Living (I-ADL)
trigger an urgent request for nursing home admission. Arch Public Health.
2012;70:2.
60. Scocco P, Rapattoni M, Fantoni G. Nursing home institutionalization: a
source of eustress or distress for the elderly? Int J Geriatr Psychiatry.
2006;21:281–7.
61. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis.
New York: Wiley; 2004.
62. Albert SM, Bear-Lehman J, Anderson SJ. Declines in mobility and changes in
performance in the instrumental activities of daily living among mildly
disabled community-dwelling older adults. J Gerontol A Biol Sci Med Sci.
2015;70:71–7.
